HI
DGX icon

HBK Investments’s Quest Diagnostics DGX Stock Holding History

HBK Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,700
Closed -$1.37M – 1246
2018
Q3 		$1.37M Buy
+12,700
New +$1.39M 0.01% 632
2018
Q1 		– Sell
-70,400
Closed -$6.93M – 1003
2017
Q4 		$6.93M Buy
70,400
+65,400
+1,308% +$6.2M 0.05% 206
2017
Q3 		$468K Buy
+5,000
New +$531K ﹤0.01% 806

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HBK Investments's DGX Position: Q4 2018 in Review

HBK Investments sold out of Quest Diagnostics (DGX) in Q4 2018, closing a stake of 12,700 shares — an estimated $1.37M sold.

HBK Investments first reported a position in DGX in Q3 2017 and held it in 3 quarters. The position peaked at $6.93M in Q4 2017. 624 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

  • HBK Investments reported no remaining Quest Diagnostics position as of Q4 2018 after selling out during the quarter.
  • HBK Investments sold 12,700 Quest Diagnostics shares in Q4 2018, an estimated $1.37M.
  • HBK Investments first reported a position in Quest Diagnostics in Q3 2017 and held it in 3 quarters.
  • HBK Investments's Quest Diagnostics position peaked at $6.93M in Q4 2017.
  • 624 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on HBK Investments's 13F filing for Q4 2018, filed 14 Feb 2019.